AC Health teams up with Taisho to expand access to Japanese healthcare products
Ayala Healthcare Holdings Inc. (AC Health), through its subsidiary AC Health Pharma, has forged a strategic partnership with Taisho Pharmaceuticals to bring Japanese healthcare products to the Philippines.
Through this partnership, AC Health Pharma and Taisho Pharmaceuticals aim to combine global healthcare expertise with strong local market reach to provide Filipinos with greater access to trusted, innovative, and high-quality healthcare solutions.
“AC Health continues to improve the affordability, accessibility, and availability of medicines for the Filipino consumer,” said AC Health Pharma President and Chief Executive Officer (CEO) Josette Adrienne Abarca.
She added, “We look forward to bringing high-quality and innovative Japanese products across AC Health’s growing network of more than 900 pharmacies, 300 corporate clinics, 17 multispecialty centers, and seven hospitals.”
Founded in 1912, Taisho Pharmaceuticals brings more than a century of consumer healthcare expertise and is recognized for its trusted portfolio of over-the-counter medications and health-related products, including Tempra, Flanax, Bonamine, Vivalyte, Biofermin, Luseco, and Locoa.
“This collaboration reflects Taisho’s long-term commitment to the Philippine market, our strong confidence in AC Health and AC Health Pharma, and our shared vision of helping more Filipinos live healthier and better lives through greater access to world-class healthcare products, services, and innovations from Japan,” said Taisho Pharmaceuticals Philippines President Jiang Peng.
The partnership also complements AC Health Pharma’s Japanese-inspired wellness pharmacy, St. Joseph Drug Powered by Sugi.
Developed in partnership with Japan’s leading drugstore chain Sugi Pharmacy, the store, located in One Ayala, combines St. Joseph Drug’s trusted local pharmacy presence with Sugi’s expertise in Japanese retail and wellness. - James A. Loyola